Fosun Pharma Is Said to Vie for $2 Billion Novartis Portfolio
An employee checks sealed packets of tablets as they move along the production line at a drug manufacturing unit (Photographer: Andrey Rudakov/Bloomberg)

Fosun Pharma Is Said to Vie for $2 Billion Novartis Portfolio

(Bloomberg) -- Shanghai Fosun Pharmaceutical Group Co. is among shortlisted bidders for a portfolio of Novartis AG assets, including its U.S. dermatology business, that could fetch as much as $2 bi...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.